Showing results (21-30 of 96) with videos related to
Sort By:
Pageof 10
Advances in Therapy|July 2, 2013
Insulin degludec once-daily in type 2 diabetes: simple or step-wise titration (BEGIN: once simple use)Athena Philis-Tsimikas, Meryl Brod, Marcus Niemeyer, et al.Journal of Diabetes Science and Technology|December 26, 2014
Novel approach to inpatient glucometric monitoring and variability in a community hospital settingJames Koziol, Keith Johnson, Kathy Brenner, et al.Journal of Diabetes Science and Technology|April 13, 2019
Efficacy and Safety of Degludec Compared to Glargine 300 Units/mL in Insulin-Experienced Patients With Type 2 Diabetes: Trial Protocol Amendment (NCT03078478)Athena Philis-Tsimikas, Irene Stratton, Lone Nørgård Troelsen, et al.Current Diabetes Reports|August 10, 2024
Are we Ready for Real-Time Continuous Glucose Monitoring in the Hospital Setting? Benefits, Challenges, and Practical Approaches for Implementation : Case Vignette: Remote Real-Time Continuous Glucose Monitoring for Hospitalized Care in Quincy KoalaAthena Philis-Tsimikas, Emily Rose N San Diego, Lauren Vincent, et al.Diabetes, Obesity & Metabolism|December 21, 2019
Benefits of insulin degludec/liraglutide are maintained even in patients discontinuing sulphonylureas or dipeptidyl peptidase-4 inhibitors upon initiation of degludec/liraglutide therapy: A post hoc analysis of the DUAL II and DUAL IX trialsAndrej Janez, Petra Őrsy, Karolina Stachlewska, et al.Diabetes Spectrum : a Publication of the American Diabetes Association|December 5, 2019
Innovative Diabetes Interventions in the U.S. Hispanic PopulationAddie L Fortmann, Kimberly L Savin, Taylor L Clark, et al.Clinical Therapeutics|December 13, 2006
Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetesAthena Philis-Tsimikas, Guillaume Charpentier, Per Clauson, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 3, 2007
Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitusDaniel Einhorn, Deirdre A Stewart, Milton K Erman, et al.Contemporary Clinical Trials|June 23, 2026
Evaluating clinical outcomes of using Undermyfork Mobile app with Dexcom G7: Protocol for CGM-Undermyfork randomized controlled trialKallie Brown, Mike Ushakov, Eugene Molodkin, et al.Diabetes Technology & Therapeutics|March 11, 2017
A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target RangesAllen B King, Athena Philis-Tsimikas, Eric S Kilpatrick, et al.Pageof 10